Characterization of Wnt/beta-catenin signalling in osteoclasts in multiple myeloma. - Test2 - elhamkhani - TriplyDB

Characterization of Wnt/beta-catenin signalling in osteoclasts in multiple myeloma.

Characterization of Wnt/beta-catenin signalling in osteoclasts in multiple myeloma.

http://www.wikidata.org/entity/Q36932713

about

Dickkopf-1 regulates bone formation in young growing rodents and upon traumatic injury Developments in sclerostin biology: regulation of gene expression, mechanisms of action, and physiological functions.Characterization of the molecular mechanism of the bone-anabolic activity of carfilzomib in multiple myeloma.Regulation of circulating sclerostin levels by sex steroids in women and in men.The Proteasome Inhibitor Carfilzomib Suppresses Parathyroid Hormone-induced Osteoclastogenesis through a RANKL-mediated Signaling Pathway.Pharmaceutical inhibition of glycogen synthetase kinase-3β reduces multiple myeloma-induced bone disease in a novel murine plasmacytoma xenograft model NELL-1 in the treatment of osteoporotic bone loss.Update on Wnt signaling in bone cell biology and bone disease.p38 MAPK in myeloma cells regulates osteoclast and osteoblast activity and induces bone destruction.Wnt Signaling Inhibits Osteoclast Differentiation by Activating Canonical and Noncanonical cAMP/PKA Pathways sFRP4-dependent Wnt signal modulation is critical for bone remodeling during postnatal development and age-related bone loss Wnt and Wnt inhibitors in bone metastasis.The osteocyte: an endocrine cell ... and more.CathepsinKCre mediated deletion of βcatenin results in dramatic loss of bone mass by targeting both osteoclasts and osteoblastic cells.Role of Wnt/β-catenin pathway in inducing autophagy and apoptosis in multiple myeloma cells.Proteasome inhibitors and bone disease.Systemic effects of Wnt signaling.Fact or fiction--identifying the elusive multiple myeloma stem cell.Emerging therapeutic targets for osteoporosis treatment.Wnt/β-catenin signaling in bone marrow niche.In vivo and in vitro effects of a novel anti-Dkk1 neutralizing antibody in multiple myeloma.Bone resorption following weight loss surgery is associated with treatment procedure and changes in secreted Wnt antagonists.Expression of Wnt3a in hepatocellular carcinoma and its effects on cell cycle and metastasis.Antagonists of Wnt/β-catenin signalling in the periodontitis associated with type 2 diabetes and smoking.RhPDCD5 combined with dexamethasone increases antitumor activity in multiple myeloma partially via inhibiting the Wnt signalling pathway.Phospholipase Cγ1 (PLCγ1) Controls Osteoclast Numbers via Colony-stimulating Factor 1 (CSF-1)-dependent Diacylglycerol/β-Catenin/CyclinD1 Pathway.

P2860

Q28584092-9FF6C2AD-6791-42EF-AA19-2B4FA20A0EBA Q33564617-FD9C89FC-2F46-44A0-AFD9-0CBEAE7A3B00 Q34997270-FC1A88BD-FEA7-44AF-A7E5-53809004B5D2 Q35094024-15ACAE10-887D-4CF0-97D9-D9D0CABCE6A3 Q35860566-D923B13E-9CC4-4F83-8334-0671E05CC5FD Q35868347-97BA3534-0873-4D3D-A7F9-ADD306A97690 Q36018565-1182525B-8258-4AA5-8019-EBB80EA23CCA Q36083303-3C9B160C-D84D-4E69-AEE8-8AF406A578C6 Q36476432-51AE2290-E4C0-4AFC-9800-34E850A5D399 Q36593417-C4493CFC-00AA-4620-B64A-C2B3B96C9C7D Q36841079-59DD31F9-9DE6-43C9-903B-8297F0FD8CD6 Q37056355-E75B37E2-4C4E-411F-BE68-411C59D2BF94 Q37203605-50655B4F-CF9E-4C2B-8B69-B69BF7E29308 Q37386387-6A7605FC-7E2F-46FA-BF64-508EA41C8CC0 Q37582380-689C381A-1292-4C69-9C03-A3D139BD8A7B Q38021042-799AEEC4-91BB-4401-AB32-8D8C11305094 Q38077507-A4B5E0F3-6868-465C-A467-F8DF8E99BBBC Q38169258-90F79EEF-37E6-406F-931E-98069AA0DA9B Q38207147-C7D91C96-6CD1-4906-8755-C423A8D296A3 Q38609596-648C3EBB-1582-4D19-A401-5D32ED8E3DC6 Q39208071-7C8BAD25-9BEE-4EF1-B926-958F0FB77FFE Q39937522-3CF2BF37-DC03-4C18-AF9B-DF1211349AD8 Q41387500-19FC2499-9AA4-4C48-ABDE-8DE4FD3E8F96 Q47291173-AB630483-2F2A-4986-933C-61E00FFA78B9 Q47747256-A121E8B3-986A-49A1-8923-CB5E5133F003 Q50287392-72CBBBC3-0C7F-4C5C-993F-3C45610A3A76

P2860

Characterization of Wnt/beta-catenin signalling in osteoclasts in multiple myeloma.

http://www.wikidata.org/entity/Q36932713

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Characterization of Wnt/beta-catenin signalling in osteoclasts in multiple myeloma.

@en

type

label

Characterization of Wnt/beta-catenin signalling in osteoclasts in multiple myeloma.

@en

prefLabel

Characterization of Wnt/beta-catenin signalling in osteoclasts in multiple myeloma.

@en

P1433

Q36932713-268E7B0F-D16B-4196-B781-3573326EE54F

P1476

Q36932713-FD179CC2-0248-4557-B46E-BDCCEDDF2A3B

P2093

Q36932713-0C2D78A1-9BDC-4DBD-9F1B-4EEEFEDED5A4

Q36932713-63964787-3295-4392-A446-330FAA8815A6

Q36932713-6A9160FD-1777-4575-834A-7FA4F28FCD9E

Q36932713-A5C7BBDC-D732-4EDE-ABE3-F1B19199AF1A

Q36932713-B8847C47-1311-47FA-8740-B6391ED00726

Q36932713-FC1A4081-DE28-4B5C-85C6-0A9E82999D68

P2860

Q36932713-13224FB2-A40C-43F8-8E40-67EBBD1046FD

Q36932713-178FC69D-D63C-46AA-A962-312033AC55C2

Q36932713-17EB3F84-3802-4660-9D03-8112584E67C5

Q36932713-1E61E125-2496-4308-A7E1-6A2CBF24248A

Q36932713-1E8F5709-7402-4D04-A977-2A4DFD027550

Q36932713-299FA7C1-D8C5-4315-9CA3-6AFC5A4C3377

Q36932713-2BF11147-3D2B-48D2-B768-687A8D4DF9B8

Q36932713-3181F911-2992-4C33-93EB-72EB56F4F06E

Q36932713-35CF5DE6-5E61-4B5C-903B-1E731BBA2825

Q36932713-38FE56C5-996C-4233-8F89-67B65F71F798

P304

Q36932713-F1AE0AEC-62FE-40E7-9B03-FDA07C80FB83

P31

Q36932713-91777641-771E-4206-BF82-D98C2496F059

P356

Q36932713-190245EA-7617-4B7D-8645-378CB89AD6ED

P407

Q36932713-635E1E07-B477-4EB1-8463-784E3D42A135

P433

Q36932713-95F31D34-B8B2-4F56-91DF-7E44EFA15EA2

P478

Q36932713-2D1744CC-273D-4362-9A9D-BC51ADDED22F

P50

Q36932713-0F5BF76D-00C2-44EA-9118-A3B758643030

P577

Q36932713-E61D1F99-0918-47C4-A5DA-2B121C8D89A4

P5875

Q36932713-48088B70-C75C-4E85-8850-33DC733F8334

P698

Q36932713-BEFB1ACF-3136-4879-B593-628F0800E3CB

P932

Q36932713-236DD9E6-19EB-474F-B275-2BCB79DAC482

P356

J.1365-2141.2009.08009.X

P1433

British Journal of Haematology

P1476

Characterization of Wnt/beta-catenin signalling in osteoclasts in multiple myeloma.

@en

P2093

Bo Hu

http://www.w3.org/2001/XMLSchema#string

John D Shaughnessy

http://www.w3.org/2001/XMLSchema#string

Joshua Epstein

http://www.w3.org/2001/XMLSchema#string

Nathan Brown

http://www.w3.org/2001/XMLSchema#string

Ya-Wei Qiang

http://www.w3.org/2001/XMLSchema#string

Yu Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Role of members of the Wnt gene family in human hematopoiesis

Secreted frizzled-related protein-1 binds directly to Wingless and is a biphasic modulator of Wnt signaling

Inhibition of adipogenesis by Wnt signaling

LDL-receptor-related proteins in Wnt signal transduction

Human dishevelled genes constitute a DHR-containing multigene family

Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma

A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait

GSK-3: tricks of the trade for a multi-tasking kinase

A transcriptional response to Wnt protein in human embryonic carcinoma cells

Wnt/beta-catenin signaling in development and disease

P304

726-738

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2141.2009.08009.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

148

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-11-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40448475

http://www.w3.org/2001/XMLSchema#string

P698

19961481

http://www.w3.org/2001/XMLSchema#string

P932

3683858

http://www.w3.org/2001/XMLSchema#string